CGT Regulatory Update and Outlook with Dark Horse Consulting's Kimberly Benton, Ph.D.
Aug 15 2024
Length: 28 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

CGT Regulatory Update and Outlook with Dark Horse Consulting's Kimberly Benton, Ph.D.

Listen for free

View show details

Summary
We love to hear from our listeners. Send us a message.
Applications (BLAs) of recent approvals and complete responses for novel products or rare diseases as well as BLAs currently under review. Benton shares information about FDA Draft Gudiances, including Platform Technology Designation Program for Drug Development: Guidance for Industry. She also provides a regulatory outlook for CGT developers.

Show more Show less

Biological Sciences

Show more Show less

What listeners say about CGT Regulatory Update and Outlook with Dark Horse Consulting's Kimberly Benton, Ph.D.

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon